Photodynamic therapy with conventional and pegylated liposomal formulations of mthpc(temoporfin): Comparison of treatment efficacy and distribution characteristics in vivo

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3817-3831

  Reshetov, Vadzim ^a,b,c   Lassalle, Henri Pierre ^a,b   François, Aurélie ^a,b,d   Dumas, Dominique ^a   Hupont, Sebastien ^a   Gräfe, Susanna ^e   Filipe, Vasco ^f   Jiskoot, Wim ^f   Guillemin, François ^a,b,d   Zorin, Vladimir ^c   Bezdetnaya, Lina ^a,b,d  

^a UNIVERSITÉ DE LORRAINE   (France)

^b CNRS   (France)

^c BELARUSIAN STATE UNIVERSITY   (Belarus)

^d Lorraine Institute of Oncology   (France)

^e Biolitec Research GmbH   (Germany)

^f LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Biodistribution; Drug release; Liposomal pharmacokinetics; Liposomes; mTHPC; Photodynamic therapy

Indexed keywords

LIPOSOME; MACROGOL; TEMOPORFIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CANCER GRAFT; CANCER RADIOTHERAPY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIODE LASER; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG STABILITY; DRUG TISSUE LEVEL; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MULTIPHOTON MICROSCOPY; NEOPLASM; NONHUMAN; PHOTOCHEMICAL QUENCHING; PHOTODYNAMIC THERAPY; TUMOR VOLUME;

BIODISTRIBUTION; DRUG RELEASE; LIPOSOMAL PHARMACOKINETICS; LIPOSOMES; MTHPC; PHOTODYNAMIC THERAPY;

ANIMALS; HT29 CELLS; HUMANS; LIGHT; LIPOSOMES; MESOPORPHYRINS; MICE; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 84885792320     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S51002     Document Type: Article

References (38)

1. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9(8):615-627.
2. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751-760.
3. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145-160.
4. Derycke AS, de Witte PA. Liposomes for photodynamic therapy. Adv Drug Deliv Rev. 2004;56(1):17-30.
5. Chen B, Pogue BW, Hasan T. Liposomal delivery of photosensitising agents. Expert Opin Drug Deliv. 2005;2(3):477-487.
6. Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250-281.
7. Senge MO, Brandt JC. Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin) - a second-generation photosensitizer. Photochem Photobiol. 2011;87(6):1240-1296.
8. Compagnin C, Moret F, Celotti L, et al. Meta-tetra(hydroxyphenyl)chlorin-loaded liposomes sterically stabilised with poly(ethylene glycol) of different length and density: characterisation, in vitro cellular uptake and phototoxicity. Photochem Photobiol Sci. 2011;10(11): 1751-1759.
9. Buchholz J, Kaser-Hotz B, Khan T, et al. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma. Clin Cancer Res. 2005;11(20):7538-7544.
10. Buchholz J, Wergin M, Walt H, Gräfe S, Bley CR, Kaser-Hotz B. Photodynamic therapy of feline cutaneous squamous cell carcinoma using a newly developed liposomal photosensitizer: preliminary results concerning drug safety and efficacy. J Vet Intern Med. 2007;21(4): 770-775.
11. Bovis MJ, Woodhams JH, Loizidou M, Scheglmann D, Bown SG, Macrobert AJ. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J Control Release. 2012;157(2):196-205.
12. de Visscher SA, Kaščáková S, de Bruijn HS, et al. Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model. Lasers Surg Med. 2011;43(6):528-536.
13. Pegaz B, Debefve E, Ballini JP, et al. Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. Eur J Pharm Sci. 2006;28(1-2): 134-140.
14. Decker C, Schubert H, May S, Fahr A. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration. J Control Release. 2013;166(3):277-285.
15. Allen TM, Cheng WW, Hare JI, Laginha KM. Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer. Anticancer Agents Med Chem. 2006;6(6):513-523.
16. Mitra S, Maugain E, Bolotine L, Guillemin F, Foster TH. Temporally and spatially heterogeneous distribution of mTHPC in a murine tumor observed by two-color confocal fluorescence imaging and spectroscopy in a whole-mount model. Photochem Photobiol. 2005;81(5):1123-1130.
17. Reshetov V, Kachatkou D, Shmigol T, et al. Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates. Photochem Photobiol Sci. 2011;10(6):911-919.
18. Coutier S, Bezdetnaya LN, Foster TH, Parache RM, Guillemin F. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice. Radiat Res. 2002;158(3):339-345.
19. Lassalle HP, Dumas D, Gräfe S, D'Hallewin MA, Guillemin F, Bezdetnaya L. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC. J Control Release. 2009;134(2):118-124.
20. Clark B, Smith DA, editors. An Introduction to Pharmacokinetics. 2nd ed. Oxford, UK: Blackwell Scientific; 1986.
21. Kachatkou D, Sasnouski S, Zorin V, et al. Unusual photoinduced response of mTHPC liposomal formulation (Foslip). Photochem Photobiol. 2009;85(3):719-724.
22. Filipe V, Hawe A, Jiskoot W. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res. 2010;27(5):796-810.
23. Reshetov V, Zorin V, Siupa A, D'Hallewin MA, Guillemin F, Bezdetnaya L. Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction. Photochem Photobiol. 2012;88(5): 1256-1264.
24. Dumas D, Hupont S, Huselstein C, et al. SHG as a new modality for large field of view imaging to monitor tissue collagen network. Biomed Mater Eng. 2012;22(1-3):159-162.
25. Malgady RG, Krebs DB. Understanding correlation coefficients and regression. Phys Ther. 1986;66(1):110, 112-114passim.
26. Taylor R. Interpretation of the correlation coefficient: a basic review. J Diagn Med Sonogr. 1990;6(1):35-39.
27. Drummond DC, Noble CO, Hayes ME, Park JW, Kirpotin DB. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. J Pharm Sci. 2008;97(11):4696-4740.
28. Kuntsche J, Freisleben I, Steiniger F, Fahr A. Temoporfin-loaded liposomes: physicochemical characterization. Eur J Pharm Sci. 2010;40(4):305-315.
29. Hefesha H, Loew S, Liu X, May S, Fahr A. Transfer mechanism of temoporfin between liposomal membranes. J Control Release. 2011;150(3):279-286.
30. Ogihara-Umeda I, Kojima S. Increased delivery of gallium-67 to tumors using serum-stable liposomes. J Nucl Med. 1988;29(4):516-523.
31. Harashima H, Hiraiwa T, Ochi Y, Kiwada H. Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling. J Drug Target. 1995;3(4):253-261.
32. Ishida T, Funato K, Kojima S, Yoda R, Kiwada H. Enhancing effect of cholesterol on the elimination of liposomes from circulation is mediated by complement activation. Int J Pharm. 1997;156(1):27-37.
33. Taurin S, Nehoff H, Greish K. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link? J Control Release. 2012;164(3):265-275.
34. Papahadjopoulos D, Allen TM, Gabizon A, et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A. 1991;88(24):11460-11464.
35. Bourdon O, Laville I, Carrez D, et al. Biodistribution of meta-tetra(hydroxyphenyl)chlorin incorporated into surface-modified nanocapsules in tumor-bearing mice. Photochem Photobiol Sci. 2002;1(9):709-714.
36. Star WM, Marijnissen HP, van den Berg-Blok AE, Versteeg JA, Franken KA, Reinhold HS. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 1986;46(5):2532-2540.
37. Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10): 806-813.
38. Garrier J, Bressenot A, Gräfe S, et al. Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis. Int J Radiat Oncol Biol Phys. 2010;78(2):563-571.